There is a significant gap in the knowledge and practice of integrating novel systemic therapies with radiotherapy in breast cancer management, particularly due to limited clinical trial data on their combined use.

This activity provides practitioners with the knowledge to recognize optimal radiotherapy management decisions for post mastectomy radiotherapy for breast cancer.

This program is designed to address the needs of a community practice physician and includes disease site reviews, interactive case-based discussions, a strategic dialogue with the ASTRO CEO and a radiation oncology practice overview.

The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.

As breast cancer survivorship improves due to advances in multimodality treatment, the number of patients at risk for local-regional recurrence is rising.

In this journal activity, participants will review the rationale for de-intensifying treatments for node-negative, hormone-receptor positive breast cancer. This activity will enable participants to be able to discuss de-escalation studies in surgery, systemic therapy and radiotherapy.

Significant advances in systemic treatment options have positively impacted breast cancer survivorship.

This activity begins with discussion on optimal ways to identify high risk patients, approaches to patient education for all women, with a specific focus on those women disproportionately affected by BCRL/UED, and clinical workflows for high risk patients/those who have already developed BCRL/UED

This activity focuses on evidence-based breast cancer contouring practices.

Patient fertility and sexual complications have few data available from clinical trials. It is noteworthy that the subject is infrequently discussed in institutional peer reviews/ M&M unless there is a Risk Management overlay.

Pages

Subscribe to RSS - Breast